Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | A-1331852 |
Trade Name | |
Synonyms | |
Drug Descriptions |
A-1331852 inhibits BCL-XL, resulting in increased tumor cell apoptosis and decreased tumor growth (PMID: 25787766, PMID: 32145345). |
DrugClasses | BCL-XL inhibitor 14 |
CAS Registry Number | 1430844-80-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
A-1210477 + A-1331852 | A-1210477 A-1331852 | 0 | 0 |
A-1331852 | A-1331852 | 0 | 0 |
A-1331852 + Alpelisib | A-1331852 Alpelisib | 2 | 0 |
A-1331852 + Buparlisib | A-1331852 Buparlisib | 0 | 0 |
A-1331852 + Docetaxel | A-1331852 Docetaxel | 0 | 0 |
A-1331852 + Ipatasertib | A-1331852 Ipatasertib | 0 | 0 |
A-1331852 + MIK665 | A-1331852 MIK665 | 0 | 0 |
A-1331852 + S63845 | A-1331852 S63845 | 0 | 0 |